1.
Emerg Infect Dis
; 27(5)2021 05.
Article
in English
| MEDLINE | ID: covidwho-1200875
ABSTRACT
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.